# A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database

> **NCT06741111** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 1233970 (actual)

## Conditions studied

- Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH)

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT06741111
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-21
- **Primary completion:** 2025-05-27
- **Final completion:** 2025-05-27
- **Target enrollment:** 1233970 (ACTUAL)
- **Last updated:** 2025-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06741111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06741111, "A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06741111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*